A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke (EvaQ)
A Prospective, Multi-Center, Single Arm Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke: The EvaQ Study
Sponsor: MIVI Neuroscience, Inc.
A NA clinical study on Acute Stroke and Cerebral Ischemia, this trial is completed. The trial is conducted by MIVI Neuroscience, Inc. and has accumulated 12 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2024 — Jul 2024 [monthly]
Completed NA
-
Oct 2023 — May 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2023 — Oct 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Nov 2022 — Jun 2023 [monthly]
Recruiting NA
Status: Enrolling By Invitation → Recruiting
-
Dec 2021 — Nov 2022 [monthly]
Enrolling By Invitation NA
-
Apr 2021 — Dec 2021 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Apr 2021 [monthly]
Enrolling By Invitation NA
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Oct 2020 — Nov 2020 [monthly]
Not Yet Recruiting NA
-
Jul 2020 — Oct 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- MIVI Neuroscience, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .